Comment on CMS-2026-1256-0002
DanaherSupportAdvocacy
Summary: Danaher Diagnostics, an advocacy organization representing the diagnostics industry, supports the proposed MS-DRG refinements and sepsis quality measures while urging CMS to maintain the NTAP alternative pathway. They argue that these policies should be structured to ensure adequate funding and recognition for innovative in vitro diagnostics to improve patient outcomes and hospital efficiency.
See attached file(s)